Escin Other names: Aescin Aesculus hippocastanum extract Horse chestnut extract

Molecular mass: 2,262.538 g/mol

Active ingredient description

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code	Group title	Classification
C05CX03	Hippocastani semen	C Cardiovascular system → C05 Vasoprotectives → C05C Capillary stabilizing agents → C05CX Other capillary stabilizing agents
Discover more medicines within C05CX03

Medicines

Escin is an active ingredient of these brands:

Brazil (BR)

(combination) HEMATOM as Escin sodium polysulphate
(combination) HEMATOM

Estonia (EE)

AESCUVEN

Hong Kong (HK)

(combination) ANFUBOL

Poland (PL)

AESCINER RETARD as HORSE CHESTNUT
REPARIL
(combination) AESCULAN as HORSE CHESTNUT
(combination) REPARIL GEL
(combination) VENOZEL

South Africa (ZA)

(combination) REPARIL GEL

Spain (ES)

FLEBOSTASIN
(combination) FEPARIL

Turkey (TR)

(combination) JELGO
(combination) PREPA-S
(combination) PREPAGEL
(combination) REPARIL GEL

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.